Vimarsana
Biggest News Aggregation in the World

Page 2 - Fed Cir News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fed Cir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fed Cir Today - Breaking & Trending Today

Statute of limitations is a key issue in Delaware trade secret dispute - Vimarsana News

Statute of limitations is a key issue in Delaware trade secret dispute

The ongoing Illumina case highlights three valuable lessons for trade secret owners in the United States: monitor former employees’ patent filings, be cognisant of the applicable statute of limitations, and carefully plead any facts that are available to support its tolling.

Patents Comparative Guide - - United States - Vimarsana News

Patents Comparative Guide - - United States

Patents Comparative Guide for the jurisdiction of United States, check out our comparative guides section to compare across multiple countries

Source: mondaq.com
Global Patent Litigation 2022 - Vimarsana News

Global Patent Litigation 2022

IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.

Panel 2 Reverses Panel 1 in Novartis v. Accord Redux - Vimarsana News

Panel 2 Reverses Panel 1 in Novartis v. Accord Redux

In other words, if an element is absent and applicant needs to argue inherent negative limitation, applicant cannot add the negative limitation to the claim, without first convincing the examiner that it is inherent in the specification

Global Patent Litigation 2022 - Vimarsana News

Global Patent Litigation 2022

IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.